276
Participants
Start Date
January 30, 2024
Primary Completion Date
February 2, 2026
Study Completion Date
February 2, 2026
MTBVAC
The MTBVAC vaccine is a freeze-dried lyophilized pellet containing live attenuated strain MTBVAC01 derived from Mycobacterium tuberculosis (M.tb). Excipients include sucrose and sodium glutamate.
BCG
The active substance in BCG vaccine is a freeze-dried powder containing live attenuated Mycobacterium bovis BCG, Danish strain 1331 and sodium glutamate as a stabilizer. The powder is white and crystalline and may be difficult to see due to the small amount contained in each vial.
RECRUITING
Soweto - Gauteng, Johannesburg
RECRUITING
Johannesburg - CHRU, Westdene
RECRUITING
Durban - Botha's Hill CRS, Durban
RECRUITING
Durban - Wentworth, Durban
RECRUITING
Worcester - SATVI, Worcester
RECRUITING
Cape Town - UCTLI, Cape Town
RECRUITING
Cape Town - Emavundleni, Cape Town
RECRUITING
Cape Town - Groote Schuur, Cape Town
RECRUITING
Cape Town - Khayelitsha, Cape Town
RECRUITING
Durban - Chatsworth, Chatsworth
NOT_YET_RECRUITING
Durban eThekwini, Durban
RECRUITING
Durban - Isipingo, Isipingo
RECRUITING
Klerksdorp, Klerksdorp
RECRUITING
Ladysmith, Ladysmith
RECRUITING
Rustenburg CRS, Rustenburg
RECRUITING
Soshanguve, Soshanguve
Collaborators (1)
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Biofabri, S.L
INDUSTRY
HIV Vaccine Trials Network
NETWORK